|
1
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
|
|
2
|
Folkman J and Ingber D: Inhibition of
angiogenesis. Semin Cancer Biol. 3:89–96. 1992.
|
|
3
|
Bicknell R and Harris AL: Anticancer
strategies involving the vasculature: vascular targeting and the
inhibition of angiogenesis. Semin Cancer Biol. 3:399–407.
1992.PubMed/NCBI
|
|
4
|
Augustin HG: Translating angiogenesis
research into the clinic: the challenges ahead. Br J Radiol.
76:3–10. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shimizu K and Oku N: Cancer
anti-angiogenic therapy. Biol Pharm Bull. 27:599–605. 2004.
View Article : Google Scholar
|
|
6
|
Purow B and Fine HA: Progress report on
the potential of angiogenesis inhibitors for neuro-oncology. Cancer
Invest. 22:577–587. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Conway EM, Collen D and Carmeliet P:
Molecular mechanisms of blood vessel growth. Cardiovasc Res.
49:507–521. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yancopoulos GD, Davis S, Gale NW, Rudge
JS, Wiegand SJ and Holash J: Vascular-specific growth factors and
blood vessel formation. Nature. 407:242–248. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tombran-Tink J, Chader GG and Johnson LV:
PEDF: A pigment epithelium derived factor with potent neuronal
differentiative activity. Exp Eye Res. 53:11–14. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Becerra SP, Sagasti A, Spinella P, et al:
Pigment epithelium-derived factor behaves like a non-inhibitory
serpin. Nerothrophic activity does not require the serpin reactive
loop. J Biol Chem. 270:25992–25999. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Filleur S, Nelius T, de Riese W and
Kennedy RC: Characterization of PEDF: a multi-functional serpin
family protein. J Cell Biochem. 106:769–775. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tombran-Tink J and Johnson LV: Neuronal
differentiation of retinoblastoma cells induced by medium
conditioned by human RPE cells. Invest Ophthalmol Vis Sci.
30:1700–1707. 1989.PubMed/NCBI
|
|
13
|
Bouck N: PEDF: anti-angiogenic guardian of
ocular function. Trends Mol Med. 8:330–334. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dawson DW, Volpert OV, Gillis P, et al:
Pigment epithelium-derived factor: a potent inhibitor of
angiogenesis. Science. 285:245–248. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Houenou LJ, D’Costa AP, Li L, et al:
Pigment epithelium-derived factor promotes the survival and
differentiation of developing spinal motor neurons. J Comp Neurol.
412:506–514. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Abe R, Shimizu T, Yamagishi S, et al:
Overexpression of pigment epithelium-derived factor decreases
angiogenesis and inhibits the growth of human malignant melanoma
cells in vivo. Am J Pathol. 164:1225–1232. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Garcia M, Fernandez Garcia NI, Rivas V, et
al: Inhibition of xenografted human melanoma growth and prevention
of metastasis development by dual antiangiogenic/antitumour
activities of pigment epithelium-derived factor. Cancer Res.
64:5632–5642. 2004. View Article : Google Scholar
|
|
18
|
Yang LP, Cheng P, Peng XC, et al:
Anti-tumour effect of adenovirus-mediated gene transfer of pigment
epithelium-derived factor on mouse B16-F10 melanoma. J Exp Clin
Cancer Res. 28:752009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Doll JA, Stellmach VM, Bouck NP, et al:
Pigment epithelium-derived factor regulates the vasculature and
mass of the prostate and pancreas. Nat Med. 9:774–780. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Filleur S, Volz K, Nelius T, et al: Two
functional epitopes of pigment epithelial-derived factor block
angiogenesis and induce differentiation in prostate cancer. Cancer
Res. 65:5144–5152. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guan M, Jiang H, Xu C, Xu R, Chen Z and Lu
Y: Adenovirus-mediated PEDF expression inhibits prostate cancer
cell growth and results in augmented expression of PAI-2. Cancer
Biol Ther. 6:419–425. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kojiro M, Hiroki I, Daisuke N, Keisuke H,
Kazuhiko N and Katsumi E: Antiangiogenic property of pigment
epithelium-derived factor in hepatocellular carcinoma. Hepatology.
40:252–259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Uehara H, Miyamoto M, Kato K, et al:
Expression of pigment epithelium-derived factor decreases liver
metastasis and correlates with favorable prognosis for patients
with ductal pancreatic adenocarcinoma. Cancer Res. 64:3533–3537.
2004. View Article : Google Scholar
|
|
24
|
Zhang L, Chen J, Ke Y, Mansel RE and Jiang
WG: Down-regulation of PEDF expression by ribozyme transgene in
endothelial and lung cancer cells and its impact on angiogenesis
in vitro. Oncol Rep. 14:1615–1619. 2005.PubMed/NCBI
|
|
25
|
Ek ET, Dass CR, Contreras KG and Choong
PF: PEDF-derived synthetic peptides exhibit antitumour activity in
an orthotopic model of human osteosarcoma. J Orthop Res.
25:1671–1680. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takenaka K, Yamagishi S, Jinnouchi Y,
Nakamura K, Matsui T and Imaizumi T: Pigment epithelium-derived
factor (PEDF)-induced apoptosis and inhibition of vascular
endothelial growth factor (VEGF) expression in MG63 human
osteosarcoma cells. Life Sci. 77:3231–3241. 2005. View Article : Google Scholar
|
|
27
|
Zhang T, Guan M, Xu C, Chen Y and Lu Y:
Pigment epithelium-derived factor inhibits glioma cell growth in
vitro and in vivo. Life Sci. 81:1256–1263. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Volpert OV, Zaichuk T, Zhou W, et al:
Inducer-stimulated Fas targets activated endothelium for
destruction by anti-angiogenic thrombospondin-1 and pigment
epithelium-derived factor. Nat Med. 8:349–357. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yamagishi S, Amano S, Inagaki Y, et al:
Pigment epithelium-derived factor inhibits leptin-induced
angiogenesis by suppressing vascular endothelial growth factor gene
expression through anti-oxidative properties. Microvasc Res.
65:186–190. 2003. View Article : Google Scholar
|
|
30
|
Yamagishi S, Inagaki Y, Amano S, et al:
Pigment epithelium-derived factor protects cultured retinal
pericytes from advanced glycation end product-induced injury
through its antioxidative properties. Biochem Biophys Res Commun.
296:877–882. 2002. View Article : Google Scholar
|
|
31
|
Cai J, Jiang WG, Grant MB and Boulton M:
Pigment epithelium-derived factor inhibits angiogenesis via
regulated intracellular proteolysis of vascular endothelial growth
fact receptor 1. J Biol Chem. 281:3604–3613. 2006. View Article : Google Scholar
|
|
32
|
Nathwani AC, Davidoff A, Hanawa H, et al:
Factors influencing in vivo transduction by recombinant
adeno-associated viral vectors expressing the human factor IX cDNA.
Blood. 97:1258–1265. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang Z, Zeng G, Zhang L, Xu C and Guo Y:
Extracellular domain of kinase domain region mediated by
adeno-associated virus inhibits growth and angiogenesis of bladder
cancer in Balb-c mice. Chin Med J (Engl). 115:1209–1212.
2002.PubMed/NCBI
|
|
34
|
Carter PJ and Samulski RJ:
Adeno-associated viral vectors as gene delivery vehicles. Int J Mol
Med. 6:17–27. 2000.PubMed/NCBI
|
|
35
|
Wu X, Dong X, Wu Z, Cao H, Niu D, et al: A
novel method for purification of recombinant adenoassociated virus
vectors on a large scale. Chinese Sci Bull. 46:485–488. 2001.
View Article : Google Scholar
|
|
36
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumour angiogenesis and metastasis - correlation in invasive
breast carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang X, Su C, Cao H, et al: A novel
triple-regulated oncolytic adenovirus carrying p53 gene exerts
poten antitumour efficacy on common human solid cancers. Mol Cancer
Ther. 7:1598–1603. 2008. View Article : Google Scholar
|
|
38
|
Hase R, Miyamoto M, Uehara H, et al:
Pigment epithelium-derived factor gene therapy inhibits human
pancreatic cancer in mice. Clin Cancer Res. 11:8737–8744. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mahtabifard A, Merritt RE, Yamada RE,
Crystal RG and Korst RJ: In vivo gene transfer of pigment
epithelium-derived factor inhibits tumour growth in syngeneic
murine models of thoracic malignancies. J Thorac Cardiovasc Surg.
126:28–38. 2003. View Article : Google Scholar : PubMed/NCBI
|
